Search

everythinglearnresearchcommunity

for

Search:↓

Scientists developed a new way to study mutations in a skin condition using blood cells, which may help diagnose and treat the disease.

Melanocyte pathology requires keratinocyte hyperplasia and regulation dysfunction.

SOX4 is crucial for the development of melanoma.

Colorectal cancer's ability to spread is due to changes in many genes, not just one.

The risk of skin tumors becoming malignant depends on the specific skin cell type affected.

PAK4 is crucial in cancer progression, brain development, and could be a therapeutic target, especially through the PAK4-CREB axis.

WNT10B is linked to cancer development and affects survival and disease progression in various cancers.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

PRSS35 enzyme may help start skin tumors and could be a target for cancer treatment.

EREG therapy may help treat hair loss by promoting hair growth.

The protein ER71/ETV2 helps regrow hair after chemotherapy by improving the growth of new blood vessels.

Targeting EGFR may help reduce hair loss from chemotherapy.

Loss of the p53 gene alone causes tumors, and losing both p53 and Rb genes speeds up aggressive skin cancer.

E211 G>A gene linked to lower risk of severe prostate cancer and hair loss.

Keratin 18 helps diagnose and predict cancer progression and affects cancer growth and spread.

Suppressing ODC activity reduces tumor growth in hair follicles.

Certain gene patterns in breast cancer are linked to how active hormone receptors are and could affect patient survival.

Erlotinib can cause scalp pustules and hair loss, needing early treatment with antibiotics and steroids.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

SOX9 helps determine stem cell roles by interacting with DNA and proteins that control gene activity.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

17β-estradiol can reduce inflammation in the skin.

Rapamycin reduces skin cell growth and tumor development by affecting cell signaling in mice.

A specific mutation in Kras causes abnormal tissue changes by making a cell signal continuously active, which disrupts normal cell coordination.

TPA strongly increases ODC activity in certain skin cells, potentially aiding tumor growth.

A rare EGFR mutation in newborns leads to severe health issues and early death.

Too much Smad7 can cause serious changes in skin tissues, including problems with hair growth, thymus shrinkage, and eye development issues.

Erlotinib can cause nonscarring hair loss and itchy skin.

TCDD reduces EGF receptors in the liver, affecting growth and development.

Antizyme slows skin tumor growth by reducing cell growth in mice.